Instagram story viewer> @profcarlepaul> Posts

profcarlepaul

@profcarlepaul

748

followers

422

following

Professor of Dermatology-Venereology, Toulouse, France
Editor in Chief, Journal of the European Academy of Dermatology and Venereology
@jeadv

POSTS STORIES REELS TAGGED

Download All

📌 Editor’s Pick 4️⃣

To close the month, Prof. Carle Paul highlights a study by Geidel et al. exploring how comorbidities may influence treatment response to immune checkpoint inhibitors in squamous-cell carcinoma. The findings underline the importance of considering patients’ overall health when evaluating treatment outcomes.

🔗 Discover more at the link in bio

#EADV #JEADV #Dermatology #SkinCancer by @profcarlepaul

29

0

21 days ago

by @profcarlepaul

74

0

a month ago

by @profcarlepaul

55

0

3 months ago

Editor’s Pick 2️⃣ is here!

This week, Prof. Carle Paul, Editor-in-Chief of JEADV, spotlights the updated EuroGuiDerm evidence-based guideline for the treatment of acne by Nast et al.

This important update addresses some of the most pressing questions in acne management, including the use of isotretinoin versus systemic antibiotics, optimal antibiotic duration, the role of hormonal therapies and spironolactone, and recommendations for newer topical treatments such as trifarotene and clascoterone.

📖 Learn more at the link in bio

#JEADV #Dermatology #AcneTreatment #ClinicalGuidelines #EuroGuiDerm by @profcarlepaul

30

0

3 months ago

by @profcarlepaul

30

3

3 months ago

🎉 It’s Friday! It’s time for July’s first Editor’s Pick!

This week, Prof. Carle Paul, Editor-in-Chief of JEADV, highlights the article by Stahl et al. on The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigo.

Managing chronic prurigo remains challenging in clinical practice. This expert consensus introduces the SWITCH algorithm, providing practical treat-to-target criteria and guidance to support treatment decisions and long-term disease management.

👀 Watch the video to discover the key insights and how the SWITCH algorithm can help optimize care for patients with chronic prurigo.

📖 Read the full article at the link in bio

#JEADV #Dermatology #ChronicPrurigo #PrurigoNodularis #ClinicalDermatology by @profcarlepaul

24

0

3 months ago

𝗜𝗺𝗽𝗮𝗰𝘁 𝗙𝗮𝗰𝘁𝗼𝗿 𝟮𝟬𝟮𝟱 📢

We are proud to announce that JEADV has achieved an Impact Factor of 9.2, increasing from 8.0 the previous year.

This milestone positions JEADV as the #1 dermatology journal in Europe and #5 worldwide in the field.

Under the leadership of Editor-in-Chief Prof. Carle Paul, this achievement reflects the dedication of our editorial team, the excellence of our authors and reviewers, and the continued trust and engagement of the global dermatology community.

Thank you to everyone who contributes to JEADV’s mission of delivering the highest level of dermatological knowledge and advancing patient care through scientific excellence.

@profcarlepaul

#JEADV #EADV #Dermatology #ImpactFactor #AcademicPublishing by @profcarlepaul

125

5

3 months ago

by @profcarlepaul

9

0

4 months ago

by @profcarlepaul

35

2

4 months ago

💫 Wrapping up the week with Editor’s Pick 4️⃣!

Prof. Carle Paul shines a spotlight on Chasset et al. with a review that covers pathogenesis, diagnosis, and management, emphasizing the role of type I interferons, validated assessment tools like CLASI, and personalized treatment strategies ranging from antimalarials to emerging biologics.

📖 Read the full article at the link in bio

#Dermatology #CutaneousLupus #SkinHealth #AutoimmuneDermatology #ClinicalDermatology by @profcarlepaul

11

0

5 months ago

Friday’s Editor’s Pick 3️⃣ is here!

Watch the video to catch the key findings highlighted by Augustin et al. on nemolizumab in atopic dermatitis. The ARCADIA long-term extension study shows sustained safety and efficacy up to 2 years in adolescents and adults with moderate-to-severe AD, offering valuable insights for long-term disease management.

📖 Discover more: link in bio

#Dermatology #AtopicDermatitis #SkinHealth #ClinicalDermatology by @profcarlepaul

24

0

5 months ago

🎉 It's Friday and it's time for the first Editor's Pick!

This week, Prof. Carle Paul, our Editor-in-Chief, highlights a must-read article by Fattore et al. on the prevention and management of cutaneous immune-related adverse events.

Immune checkpoint inhibitors are transforming cancer care, but dermatologic toxicities are among the most common immune-related adverse events. This Task Force statement reviews risk factors and offers evidence-based strategies to prevent and manage cirAEs, helping clinicians reduce their impact on patients’ lives.

👀 Watch the video for key insights and discover practical tips for cirAE management.

📖 Learn more: link in bio

#Dermatology #SkinHealth #ClinicalDermatology by @profcarlepaul

27

1

5 months ago